AOD9604 is a synthetic analogue of the C-terminal fragment of human growth hormone (hGH176-191). In published research, it is studied as a fragment peptide with a modified structure that dissociates lipolytic signalling activity from the anabolic properties of full-length hGH. It is a subject of study in adipose-tissue signalling research and fragment-peptide pharmacology.

Areas of Research Interest:

• Studied in adipose-tissue signalling research for lipolytic pathway engagement
• Examined as a structural fragment of hGH176-191 in fragment-peptide pharmacology
• Of interest in growth-hormone fragment research separated from anabolic pathways
• Investigated in lipid-metabolism signalling research

Primary research areas: Adipose-tissue signalling | Fragment-peptide pharmacology | hGH fragment biology | Lipid metabolism signalling

REGULATORY NOTICE
FOR LABORATORY RESEARCH USE ONLY — NOT INTENDED FOR HUMAN OR VETERINARY CONSUMPTION

Not a medicinal product, pharmaceutical, food supplement, or cosmetic. Not evaluated or approved by the MHRA, FDA, or any regulatory
authority for use in humans or animals. Must not be used for diagnostic, therapeutic, or preventative purposes.
Must be handled only by qualified professionals within a suitable research environment. By purchasing you confirm research-only use.
Purchasers must be 18+. PerformanceLabsUK accepts no liability for misuse.